
Janette McKnight
New Business Development Manager
Johnson Matthey
About me
If you’re interested in learning how Johnson Matthey can support your small molecule development with catalysis, I’d love to connect.
I specialise in helping innovators across the EMEA region identify optimal catalysts for their processes, partnering with organisations ranging from small enterprises and start-ups to global corporations.
I hold a DPhil in Organic Chemistry from the University of Oxford, where my research focused on palladium-catalysed desulfinative cross-coupling reactions, published in collaboration with Pfizer.
Social media
Is member of

Johnson Matthey
Exhibitorsis attending
Navigating Shifts in CDMO-Pharma Relations: Trends and Implications
Tuesday, October 8, 2024 9:35 AM to 10:30 AM
Hall 5 - 5B49
Gil Roth · Pharma & Biopharma Outsourcing Association
Faye Boeckman · Thermo Fisher Scientific
Empowering API Manufacturing: Perspectives From a Contract Development and Manufacturing Organization
Wednesday, October 9, 2024 1:15 PM to 1:40 PM
Hall 5 - 5B49
Joerg Ahlgrimm · SK pharmteco
A Case Study with Roche on the Integrated Continuous Manufacturing of Pharmaceuticals
Wednesday, October 9, 2024 1:45 PM to 2:10 PM
Hall 5 - 5B49
Stephen Born · CONTINUUS PHARMACEUTICALS
Maximizing Outsourcing and Manufacturing Success Through Strategic CDMO and CRO Partnerships
Wednesday, October 9, 2024 11:45 AM to 12:10 PM
Hall 5 - 5B49
Jennifer Cannon · Thermo Fisher Scientific
Pharma’s Innovation Catalyst: How Partnerships, Investments, and Acquisitions Are Shaping Healthcare's Future
Thursday, October 10, 2024 9:35 AM to 10:30 AM
Hall 5 - 5B49
Jan Vertommen · Lonza